2
©2010 Abbott Medical Optics Inc. Abbott trademarks and products in-licensed by Abbott are shown in bold and italics. 2009.07.01-IL1126 Rev. A www.amo-ilasik.com Only iLASIK Can Laser assisted in-situ keratomileusis (LASIK) can only be performed by a trained ophthalmologist and for specified reduction or elimination of myopia, hyperopia, and astigmatism as indicated within the product labeling. Laser refractive surgery is contraindicated for patients: a) with collagen vascular, autoimmune, or immunodeficiency diseases; b) who are pregnant or nursing women; c) with signs of keratoconus or abnormal corneal topography; d) who are taking one or both of the following medications: Isotretinoin (Accutane) and Amiodarone hydrochloride (Cordarone). Potential side effects to laser refractive surgery may include glare, dry eye, as well as other visual anomalies. LASIK requires the use of a microkeratome that cuts a flap on the surface of the cornea, potential side effects may include flap related complications. Patients are requested to consult with their eye care professional and Patient Information Booklet regarding the potential risks and benefits for laser refractive surgery, results may vary for each individual patient. Restricted Device: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care practitioner. U.S. Federal Law restricts the use of this device to practitioners who have been trained in its calibration and operation and who have experience in the surgical treatment and management of refractive errors. *20/16 results delivered with excimer laser; clinical studies sent to FDA via P930016 supplement 021. Innovative Technologies Delivering Exceptional Results Beyond 20/20 The iLASIK Technology Suite provides a truly customized treatment, helping you take more of your patients beyond 20/20 vision* Good Enough for NASA and Your Patients NASA astronauts can have laser vision correction surgery today because of the exclusive, validated safety and precision performance of iLASIK Technologies Leading Innovation With over 20 years of innovation and more than 10 million procedures worldwide, iLASIK Technologies are the true industry leaders Unmatched Support. Unsurpassed Value. Our post-sales support enhances the value of your investment in the premium iLASIK Platform by maximizing reliability, quality and patient outcomes

ParkAvenueLasek.com - iIntraLase iLasek Technology

Embed Size (px)

Citation preview

©2010 Abbott Medical Optics Inc. Abbott trademarks and products in-licensed by Abbott are shown in bold and italics. 2009.07.01-IL1126 Rev. A

www.amo-ilasik.com

Only iLASIK Can

Laser assisted in-situ keratomileusis (LASIK) can only be performed by a trained ophthalmologist and for specified reduction or elimination of myopia, hyperopia, and astigmatism as indicated within the product labeling. Laser refractive surgery is contraindicated for patients: a) with collagen vascular, autoimmune, or immunodeficiency diseases; b) who are pregnant or nursing women; c) with signs of keratoconus or abnormal corneal topography; d) who are taking one or both of the following medications: Isotretinoin (Accutane) and Amiodarone hydrochloride (Cordarone). Potential side effects to laser refractive surgery may include glare, dry eye, as well as other visual anomalies. LASIK requires the use of a microkeratome that cuts a flap on the surface of the cornea, potential side effects may include flap related complications. Patients are requested to consult with their eye care professional and Patient Information Booklet regarding the potential risks and benefits for laser refractive surgery, results may vary for each individual patient. Restricted Device: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care practitioner. U.S. Federal Law restricts the use of this device to practitioners who have been trained in its calibration and operation and who have experience in the surgical treatment and management of refractive errors.

*20/16 results delivered with excimer laser; clinical studies sent to FDA via P930016 supplement 021.

Innovative Technologies Delivering Exceptional Results

Beyond 20/20 – The iLASIK Technology Suite provides a truly customized

treatment, helping you take more of your patients beyond 20/20 vision*

Good Enough for NASA and Your Patients – NASA astronauts can have laser vision correction surgery

today because of the exclusive, validated safety and precision performance of iLASIK Technologies

Leading Innovation – With over 20 years of innovation and more than 10 million

procedures worldwide, iLASIK Technologies are the true industry leaders

Unmatched Support. Unsurpassed Value. – Our post-sales support enhances the value of your investment

in the premium iLASIK Platform by maximizing reliability, quality and patient outcomes

Advanced CustomVue Technology

IntraLase Technology

“”

The iLASIK Technology Suite, the exclusive combination of IntraLase and Advanced CustomVue Technologies, is an integrated solution that delivers high satisfaction for the broadest range of patients.

Technology That’s Better Together

“The combination of technologies that make up the iLASIK Suite have made

a significant difference in the quality and consistency of my refractive surgery

outcomes. I’m seeing more patients with 20/16 or better visual acuity and a

number reporting excellent night vision. Equally impressive was how quickly

patients arrive at those points. I typically see patients reporting the absence of

night vision symptoms in the week following surgery.”

Robert K. Maloney, MD